NCT03717805

Brief Summary

The Preparatory information on Oocyte Aspiration Movie Randomized Controlled Trial (POAM-RCT) primarily aims to evaluate whether a new preparatory information on oocyte aspiration movie (POAM) decreases the anxiety of women on the day of their first oocyte aspiration for in vitro fertilisation (IVF). The control group of this RCT will receive care as usual. The intervention group will additional be given access to a preparatory information movie on oocyte aspiration 1-3 days before their oocyte aspiration via a secured link. Women's anxiety will be assessed with the 'State module of the State Trait Anxiety Inventory (STAI-state)' upon arrival at the fertility clinic on the day of the oocyte aspiration. At the same time other questionnaires will be administered. More specifically, men's anxiety and both partner's infertility specific distress will be assessed. In addition, to these secondary outcomes, clinical pregnancy with fetal heart beat and miscarriage will be followed-up 12 weeks after the oocyte aspiration. Finally, treatment delay and treatment discontinuation and long-term clinical outcomes (i.e. live birth from the first fresh embryo transfer, clinical pregnancy with fetal heart beat from the frozen embryo transfers of 1st IVF-cycle and the 12-months cumulative clinical pregnancy rates) will be followed-up twelve months after oocyte aspiration. This RCT will include 190 women (and their male partners) treated with a 1st cycle of IVF (with or without ICSI and PGD). Analysis will be according to intention to treat.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
155

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Oct 2018

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 10, 2018

Completed
14 days until next milestone

First Posted

Study publicly available on registry

October 24, 2018

Completed
5 days until next milestone

Study Start

First participant enrolled

October 29, 2018

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 24, 2020

Completed
2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

September 24, 2022

Completed
Last Updated

August 20, 2024

Status Verified

July 1, 2024

Enrollment Period

1.9 years

First QC Date

October 10, 2018

Last Update Submit

August 19, 2024

Conditions

Keywords

Patient-centered carePatient information

Outcome Measures

Primary Outcomes (1)

  • Women's state anxiety

    Women's anxiety will be assessed with the 'State Trait Anxiety Inventory, state module (STAI-state; score 20-80, the higher the more anxious)' questionnaire (Spielberger et al, 2015; www.mingarden.com).

    Responses on one single assessment of state-anxiety on the day of the oocyte aspiration (1-3 days after the intervention or control condition) will be compared between intervention and control group. No pre-intervention assessment, no change scores.

Secondary Outcomes (10)

  • Men's state anxiety

    Responses on one single assessment of state-anxiety on the day of the oocyte aspiration (1-3 days after the intervention or control condition) will be compared between intervention and control group. No pre-intervention assessment, no change scores.

  • Women's infertility specific distress

    Responses on one single assessment of distress on the day of the oocyte aspiration (1-3 days after the intervention or control condition) will be compared between intervention and control group. No pre-intervention assessment, no change scores.

  • Men's infertility specific stress

    Responses on one single assessment of distress on the day of the oocyte aspiration (1-3 days after the intervention or control condition) will be compared between intervention and control group. No pre-intervention assessment, no change scores.

  • Clinical pregnancy with fetal heart beat

    A medium duration after intervention or control condition: 12 weeks after oocyte aspiration

  • Miscarriage after clinical pregnancy with fetal heart beat

    A medium duration after intervention or control condition: 12 weeks after oocyte aspiration

  • +5 more secondary outcomes

Study Arms (2)

Intervention group

EXPERIMENTAL

Participating couples of the intervention group will receive care as usual and will watch the preparatory information movie on oocyte aspiration (POAM) 1-3 days before their oocyte aspiration. Their gynecologist or midwife will empower them to watch the movie when they call them to plan the oocyte aspiration and will send them the secured link to the movie via email.

Other: POAM

Control group

NO INTERVENTION

Participating couples of the control group will receive care as usual (as will participating couples of the intervention group) and will not get access to the preparatory information movie on oocyte aspiration (POAM).

Interventions

POAMOTHER

The new 5 minutes preparatory information movie on oocyte aspiration (POAM) details what couples can expect to happen on the day of oocyte aspiration. More specifically, it describes the patient journey detailing which procedures will happen when and how, in which room, in the presence of their partner or not, and in the presence of which healthcare professionals.

Intervention group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • (i) Heterosexual woman and her partner
  • (ii) Dutch speaking
  • (iii) Treated with a 1st cycle of IVF (IVF or ICSI; with or without PGD)

You may not qualify if:

  • (i) Having already experienced an IVF-cycle in the same of another clinic

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

GZA Ziekenhuizen campus Sint-Augustinus

Wilrijk, Antwerpen, 2610, Belgium

Location

Related Publications (1)

  • Dias L, De Loecker P, Willems S, D'Hooghe TM, Vriens J, Peeraer K, Dancet EAF. A video clip detailing the patient journey on the day of oocyte retrieval in addition to the standard of care: a randomized controlled trial. Hum Reprod. 2025 Apr 1;40(4):664-674. doi: 10.1093/humrep/deaf033.

MeSH Terms

Conditions

Infertility

Condition Hierarchy (Ancestors)

Genital DiseasesUrogenital Diseases

Study Officials

  • Karen Peeraer, PhD

    Universitaire Ziekenhuizen KU Leuven

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: Randomized controlled trial (1/1)
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 10, 2018

First Posted

October 24, 2018

Study Start

October 29, 2018

Primary Completion

September 24, 2020

Study Completion

September 24, 2022

Last Updated

August 20, 2024

Record last verified: 2024-07

Data Sharing

IPD Sharing
Will not share

Locations